ICON Opens Shanghai Office

ICON plc has continued its expansion in the Asia-Pacific by opening a new office in Shanghai, China, and is also relocating its Beijing operations to larger premises. In addition, ICON has announced the appointment Dr. Malcolm Burgess to the position of executive vice president, Asia-Pacific, and Paula Mumby to vice president, Operations, Asia-Pacific for ICON’s resourcing business unit, DOCS.

Commenting on the announcement, Peter Gray, ICON’s chief executive officer, said, “China is currently the third largest pharmaceutical market in the world and will soon become the second largest, as more and more pharmaceutical companies move their research to this region. We are growing our presence in this important market, as well as the broader Asia-Pacific region, and we have a highly experienced leadership team in place to support our plans for further growth.”

Dr. Burgess joined ICON in 2002 and has held a variety of leadership positions within the company, including chief operating officer, U.S. Operations from 2006 to 2009. He has more than 30 years’ experience within the pharmaceutical industry and prior to ICON worked with Novartis, Hoechst Marion Roussel and SmithKline Beecham.

Ms. Mumby has more than 18 years’ experience in the pharmaceutical, CRO, biotechnology and medical device industries in the UK and Asia Pacific and has more than 10 years’ resourcing experience. Prior to joining DOCS, Ms. Mumby was vice president, Asia Pacific and Japan at i3 Pharma Resourcing and also held a clinical development role at CSL.